![Michel Detheux](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michel Detheux
Directeur/Membre du Conseil chez
VOR BIOPHARMA INC.
Fortune : - $ au 31/07/2026
Profil
Michel Detheux is the founder of iTeos Therapeutics SA, founded in 2011, serving as President, Chief Executive Officer & Director.
Dr. Detheux was the founder of iTeos Therapeutics, Inc., founded in 2012, and served as President, Chief Executive Officer & Director from 2012 to 2025.
Current jobs include Chief Executive Officer at Muna Therapeutics ApS starting in 2026, Chairman at Egle Therapeutics SAS, Chairman at Innoskel SASU since 2022, and Independent Director at Vor Biopharma, Inc. since 2025.
Former jobs include President, Chief Executive Officer & Director at iTeos Belgium SA, Independent Chairman at Ona Therapeutics SL from 2021 to 2025, Executive Director at Ogeda SA, and Director at Ludwig Institute For Cancer Research Ltd. (New York) from 2010 to 2012.
Education includes a doctorate from Université Catholique de Louvain.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VOR BIOPHARMA, INC. -.--% | 11/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Michel Detheux
| Sociétés | Poste | Début |
|---|---|---|
| VOR BIOPHARMA INC. | Directeur/Membre du Conseil | 16/07/2025 |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Fondateur | 01/01/2011 |
Innoskel SASU
 Innoskel SASU BiotechnologyHealth Technology Develops novel therapies | Président | 12/04/2022 |
Egle Therapeutics SAS
 Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases | Président | - |
Muna Therapeutics ApS
 Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Directeur Général | 29/06/2026 |
Anciens postes connus de Michel Detheux
| Sociétés | Poste | Fin |
|---|---|---|
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases | Président | 14/10/2025 |
| ITEOS THERAPEUTICS, INC. | Fondateur | 28/08/2025 |
Ludwig Cancer Research | Directeur/Membre du Conseil | 01/04/2012 |
Iteos Belgium SA
 Iteos Belgium SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical raw materials | Directeur Général | - |
| ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Michel Detheux
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Ona Therapeutics SL
Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Health Technology |
Innoskel SASU
Innoskel SASU BiotechnologyHealth Technology Develops novel therapies | Health Technology |
Egle Therapeutics SAS
Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases | Health Technology |
Iteos Belgium SA
Iteos Belgium SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical raw materials | Health Technology |
Ludwig Cancer Research |
